The non -coding genome, after being rejected as “DNA garbage”, is now recognized as a fundamental regulator of gene expression and as a key player in understanding complex diseases. Following the milestone achievements of the work of the human genome (HGP), scientists are increasingly focusing on decryption of non -coding areas of the human genome, which include about 98% of genetic material.
These areas, which are largely overlooked because of their non -protein coding, are now known to host regulatory elements that are critical to the functioning of cells and the progression of the disease.
The awareness that the non -coding DNA plays a central role in the regulation of genes has transformed how scientists understand genomic architecture. Unifying approaches, the combination of genomic, epiginomic, transcriptional and proteinma, have revealed that non -coding areas are not only present but actively involved in the control of gene expression through a network of amplifiers, promotions and modifications. These elements are involved in the three -dimensional genome organization, allowing long -range interactions that regulate cellular function.
Progress in Sequence of Next Generation (NGS) has contributed to the regulatory disclosure potential of non -coding genome. High performance techniques such as chip-seq, ATAC-SEQ and RNA-SEQ have allowed the identification of transcript commitment, open chromatin Areas, and non -coded RNA transcripts (NCRNA).
In addition, methods such as chromosome configuration arrest (3C) and Hi-C provided information on chromatin architecture, highlighting the spatial relationships between amplifiers and promoters.
A basic discovery lies in understanding the way in which non -coded variants contribute to the disease. Studies have shown that mutations in amplifier areas, promoter sequences and RNA regulatory sequences can disrupt gene expression, leading to various genetic disorders and cancers.
For example, mutations in SNCA gene reinforcement elements are associated with Parkinson’s disease, while changes in the promoter Tert are associated with cancer progress. These findings emphasize the importance of non -coded DNA in maintaining genomic stability and the prevention of pathological transformations.
The transition from seeing non -coding DNA as biological noise to recognize its regulatory The importance marks the displacement of genomic medicine. As the researchers continue to map the regulatory landscapeMIMedical accuracy is becoming more and more apparent. With the targeting of non -encoding elements involved in the etiology of the disease, it may be possible to develop custom therapies facing the main causes of gene dysfunction.
Source:
Magazine report:
Ruffo, p., et al. (2025). Revealing the regulatory potential of the non -coding genome: information from the work of the human genome to precision medical medical. Genes and diseases. doi.org/10.1016/j.gendis.2025.101652
